Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent
Psychopharmacology Bulletin · 12.08.2025 · 55 (2) · 94-99
DOI: 10.64719/pb.4525 ↗Kurz gefasst
Fallbericht in der Zeitschrift Psychopharmacology Bulletin, online erschienen am 12.08.2025. Verfasst von Anna Mori-Kreiner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mori-Kreiner, University of Missouri School of Medicine, Columbia, Missouri, United States. Hauptthemen laut MEDLINE: Hallucinogens, Hallucinations, Perceptual Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Hallucinogen-persisting Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of one or more perceptual symptoms that an individual experienced while intoxicated with a hallucinogenic substance when the individual is sober. While there are several case reports of HPPD in adult patients, there is a scarcity of documented cases in children and adolescents. The purpose of this article is to highlight the presentation, diagnosis, and treatment of HPPD in a 16-year-old male patient.
Methods
In this case report, the patient is a 16-year-old male with a history of major depressive disorder (MDD) and polysubstance use using Lysergic acid diethylamide (LSD), 3,4-Methylenedioxymethamphetamine (MDMA), psilocybin, cannabis, and benzodiazepines. He endorsed having auditory hallucinations and a heightened sense of hearing in between usage of MDMA for the past eight months and described auditory and visual hallucinations during his 5-day admission at the inpatient child psychiatric unit. Aripiprazole 5 mg was used as treatment for HPPD.
Results
On review of literature, the first-line treatment for HPPD with clonidine and benzodiazepine has been documented by few case reports. Second generation antipsychotics are documented to be less effective with the exception of aripiprazole. The authors witnessed gradual improvement in the patient’s symptoms with the use of aripiprazole, although it was not completely resolved during his hospital course.
Conclusions
This case demonstrates the presentation of HPPD and efficacy of aripiprazole in an adolescent patient. The diagnosis was further complicated by the patient’s history of polysubstance use, and determining a distinction from non-substance-induced psychotic disorders was paramount.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mori-Kreiner, University of Missouri School of Medicine, Columbia, Missouri, United States.
- Aggarwal, University of Missouri School of Medicine, Columbia, Missouri, United States.
- Bordoloi, University of Missouri School of Medicine, Columbia, Missouri, United States.
Zitieren
APA
Mori-Kreiner, A., Aggarwal, A., & Bordoloi, M. (2025). Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent. Psychopharmacology Bulletin, 55(2), 94-99. https://doi.org/10.64719/pb.4525
Vancouver
Mori-Kreiner A, Aggarwal A, Bordoloi M. Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent. Psychopharmacology Bulletin. 2025;55(2):94-99. doi:10.64719/pb.4525
BibTeX
@article{MoriKreiner2025,
author = {Mori-Kreiner, Anna and Aggarwal, Arpit and Bordoloi, Meelie},
title = {Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent},
journal = {Psychopharmacology Bulletin},
year = {2025},
volume = {55},
number = {2},
pages = {94--99},
doi = {10.64719/pb.4525}
}
EUVIMED